STOCK TITAN

UPDATE — Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 7:00 p.m. Eastern Time. The event will take place at the Terranea Resort in Rancho Palos Verdes, CA, with a live webcast accessible at this link. A replay will be available for two weeks on Inspire's Investor website. The company specializes in innovative, minimally invasive treatments for obstructive sleep apnea, including the FDA-approved Inspire therapy, the first neurostimulation technology for this condition.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, June 06, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022 at the Terranea Resort in Rancho Palos Verdes, CA.

Inspire is scheduled to present at 7:00 p.m. Eastern Time. The presentation will be accessible via a live webcast at https://kvgo.com/gs/inspire-medical-systems-inc-june-2022.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989


FAQ

When is Inspire Medical Systems presenting at the Goldman Sachs conference?

Inspire Medical Systems will present on June 14, 2022, at 7:00 p.m. Eastern Time.

Where is the Goldman Sachs Global Healthcare Conference being held?

The conference is taking place at the Terranea Resort in Rancho Palos Verdes, CA.

How can I watch the Inspire Medical Systems presentation?

The presentation will be available via a live webcast at a specific link, with a replay accessible for two weeks on Inspire's Investor website.

What does Inspire Medical Systems specialize in?

Inspire Medical Systems focuses on developing innovative, minimally invasive solutions for patients with obstructive sleep apnea.

What is Inspire's FDA-approved therapy?

Inspire's proprietary therapy is the first FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.56B
29.36M
1.95%
115.29%
7.48%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY